Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1208

1.

Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer.

Gore JL, Kwan L, Lee SP, Reiter RE, Litwin MS.

J Natl Cancer Inst. 2009 Jun 16;101(12):888-92. doi: 10.1093/jnci/djp114. Epub 2009 Jun 9.

PMID:
19509365
2.

Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.

Ferrer M, Suárez JF, Guedea F, Fernández P, Macías V, Mariño A, Hervas A, Herruzo I, Ortiz MJ, Villavicencio H, Craven-Bratle J, Garin O, Aguiló F; Multicentric Spanish Group of Clinically Localized Prostate Cancer..

Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):421-32. doi: 10.1016/j.ijrobp.2007.12.024. Epub 2008 Mar 5.

PMID:
18325680
3.

Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study.

Potosky AL, Legler J, Albertsen PC, Stanford JL, Gilliland FD, Hamilton AS, Eley JW, Stephenson RA, Harlan LC.

J Natl Cancer Inst. 2000 Oct 4;92(19):1582-92.

PMID:
11018094
4.

Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.

Potosky AL, Davis WW, Hoffman RM, Stanford JL, Stephenson RA, Penson DF, Harlan LC.

J Natl Cancer Inst. 2004 Sep 15;96(18):1358-67.

PMID:
15367568
5.

Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy.

Miller DC, Sanda MG, Dunn RL, Montie JE, Pimentel H, Sandler HM, McLaughlin WP, Wei JT.

J Clin Oncol. 2005 Apr 20;23(12):2772-80.

PMID:
15837992
6.

Quality of life after treatment for prostate cancer.

Penson DF, Litwin MS.

Curr Urol Rep. 2003 Jun;4(3):185-95. Review.

PMID:
12756081
8.

Quality of life two years after radical prostatectomy, prostate brachytherapy or external beam radiotherapy for clinically localised prostate cancer: the Catalan Institute of Oncology/Bellvitge Hospital experience.

Guedea F, Ferrer M, Pera J, Aguiló F, Boladeras A, Suárez JF, Cunillera O, Ferrer F, Pardo Y, Martínez E, Ventura M.

Clin Transl Oncol. 2009 Jul;11(7):470-8.

PMID:
19574206
9.

Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy.

Lilleby W, Fosså SD, Waehre HR, Olsen DR.

Int J Radiat Oncol Biol Phys. 1999 Mar 1;43(4):735-43.

PMID:
10098428
10.
11.

Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer.

Litwin MS, Gore JL, Kwan L, Brandeis JM, Lee SP, Withers HR, Reiter RE.

Cancer. 2007 Jun 1;109(11):2239-47.

12.

Effect of treatment on quality of life among men with clinically localized prostate cancer.

Schapira MM, Lawrence WF, Katz DA, McAuliffe TL, Nattinger AB.

Med Care. 2001 Mar;39(3):243-53.

PMID:
11242319
13.

Quality of life outcomes after brachytherapy for early stage prostate cancer.

Brandeis JM, Litwin MS, Burnison CM, Reiter RE.

J Urol. 2000 Mar;163(3):851-7.

PMID:
10687991
16.

An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.

Frank SJ, Pisters LL, Davis J, Lee AK, Bassett R, Kuban DA.

J Urol. 2007 Jun;177(6):2151-6; discussion 2156. Erratum in: J Urol. 2007 Sep;178(3 Pt 1):1125.

PMID:
17509305
17.

Time course and predictors of symptoms after primary prostate cancer therapy.

Talcott JA, Manola J, Clark JA, Kaplan I, Beard CJ, Mitchell SP, Chen RC, O'Leary MP, Kantoff PW, D'Amico AV.

J Clin Oncol. 2003 Nov 1;21(21):3979-86.

PMID:
14581420
18.

Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer--data from CaPSURE.

Downs TM, Sadetsky N, Pasta DJ, Grossfeld GD, Kane CJ, Mehta SS, Carroll PR, Lubeck DP.

J Urol. 2003 Nov;170(5):1822-7.

PMID:
14532784
19.
20.

Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment.

Pardo Y, Guedea F, Aguiló F, Fernández P, Macías V, Mariño A, Hervás A, Herruzo I, Ortiz MJ, Ponce de León J, Craven-Bratle J, Suárez JF, Boladeras A, Pont À, Ayala A, Sancho G, Martínez E, Alonso J, Ferrer M.

J Clin Oncol. 2010 Nov 1;28(31):4687-96. doi: 10.1200/JCO.2009.25.3245. Epub 2010 Oct 4. Erratum in: J Clin Oncol. 2011 Feb 20;29(6):779.

PMID:
20921463

Supplemental Content

Support Center